What did members of the international development community think of the blueprint the United States released last week to outline its role and contributions toward achieving an AIDS-free generation?
The reactions were mixed, as Devex has noted. In general, aid groups welcomed the release of the blueprint and urged other donors to follow the United States’ lead. There are, however, some groups that were disappointed with the lack of concrete funding commitments, among other details.
DAI, a leading U.S. contractor, for instance, said the blueprint, despite not being necessarily new, was an important milestone. It added that it is particularly excited over the outlined focus on science and evidence. But the U.S. government could have gone beyond shared responsibility between private and public sectors and highlighted shared accountability, DAI told Devex in an email.
Another major U.S. Agency for International Development partner, Management Sciences for Health, also lauded the focus on innovation and evidence-based activities. World Vision, meanwhile, said it was pleased with the document’s focus on children, but had hoped for more discussions of financial commitments.
Funding was among aspects a New York Times editorial said the U.S. government failed to deliver in its blueprint. It noted that the document also “failed to set firm goals for the percentage of people to be provided with treatments or the reduction in disease to be achieved.”
Here’s what other members of the international community had to say about the new blueprint:
“We welcome the focus on responses that are epidemic based, and the particular attention to women and girls. We appreciate the focus on key affected populations, and with 40% of new infections among youth, and we hope there will be sufficient emphasis on younger member of key affected populations and those living with HIV.”
Greg Ramm, associate vice president for child protection and HIV and AIDS, Save the Children.
“In particular, the roadmap for smart investments which ‘target efforts where the virus is’ must be applauded. The targeting of HIV-associated tuberculosis (TB) and reduction of co-morbidity also builds on PEPFAR’s experience over the years.”
John Stephen Osika, senior HIV, AIDS and communicable diseases adviser, Abt Associates.
“The increased commitment on ensuring value for money, especially for ARVs and strengthened supply chains, as well as aligning efficiencies through work with the Global Fund is particularly important. It was surprising that the connection between sustainable, country-owned programs and efforts to strengthen in-country health systems did not receive greater mention. We had hoped that the new blueprint would focus more on the importance of narrowing the funding gap through increased donor and country level financial commitment.”
Ann Lion, vice president of Abt’s international health division, and member, Global Fund to Fight AIDS, Tuberculosis and Malaria’s finance and operational performance committee.
“Never in the history of the AIDS response have we been so aligned in our priorities, our mutual respect and in our shared motivation for results. We must commit to immediately bring countries and resources together—to close the capacity gap between where we are today and where we must be tomorrow.”
Michel Sidibé, executive director, UNAIDS
Join the debate on this new U.S. blueprint. Share your impression of the document in the comment section below. Does the blueprint offer anything new? What is its most noteworthy aspect? What could be improved on?
Adrienne Valdez contributed reporting
Read more on U.S. aid reform online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.